This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Resolved

ESTRADOT 75

SANDOZ CANADA INCORPORATED

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ESTRADOT 75 in Canada?

Yes. ESTRADOT 75 75MCG has an active shortage reported to Health Canada (last updated October 29, 2026).

Why is ESTRADOT 75 not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will ESTRADOT 75 be available again?

The manufacturer's estimated resolution date is December 18, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength75MCG

Report last updated2026-06-16

Checked by MedShort2026-11-13

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02244001

Strength

75MCG

Dosage Form

PATCH

Route

TRANSDERMAL

Active Ingredient

ESTRADIOL

Tier

Unrated

Last Updated

2026-06-16

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

ESTRADOT 75 has 2 shortage/discontinuation reports on file — this is one of them.

2026-10-29

Active Shortage

Disruption of the manufacture of the drug.

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929